iiinova — where your digital self keeps evolving

bastianengel.bsky.social @bastianengel.bsky.social · 04/12/2025

Richard Taubert and I had the pleasure talking with @heinerwedemeyer.bsky.social @mhh about the spectrum of #AutoimmuneHepatitis, #DILI and #DI-ALH @dgvs podcast. Thank you for having us to speak about current topics in this exiting field (in german). Feel free to listen! lnkd.in/eAjZ7KX9

lnkd.in

This link will take you to a page that’s not on LinkedIn

020

bastianengel.bsky.social @bastianengel.bsky.social · 30/07/2025

🔥 non-medical 🌎 planetary health is critical Check out this video by naturalists about sustainable tourism and ocean protection on the Azores. Scientist-led, EU-funded 🇪🇺 Happy to have joined this year. Check it out. support them if you visit the Azores. www.euronews.com/green/2025/0...

euronews.com

How Atlantic islands are proving tourism can help the ocean

From underwater archaeology to whale-watching tours led by actual scientists, Europe’s Atlantic islands demonstrate how tourism can protect rather than destroy natural and cultural heritage of the oce...

020

bastianengel.bsky.social @bastianengel.bsky.social · 17/07/2025

🔥 Publication alert from us! 🧬 Distinct molecular profiles of AMR and TCMR after #liver #transplant 📈 AMR associates w/ high rate of graft #cirrhosis 🧪 IFN mediates TCMR, TNF mediates AMR as in other SOT doi.org/10.1016/j.jh... #openaccess @jhepatology.bsky.social #liversky @easlnews.bsky.social

doi.org

Redirecting

020

bastianengel.bsky.social @bastianengel.bsky.social · 15/07/2025

🔥 Publication alert from our group! 🧬 Distinct molecular profiles of AMR and TCMR after #liver #transplant 📈 AMR associates w/ high rates of graft #cirrhosis 🧪 IFN mediates TCMR and TNF mediates AMR as in other solid organs #openaccess @jhepatology.bsky.social #liversky @easlnews.bsky.social

130

Reposted by @bastianengel.bsky.social

Jan Clusmann @janclusmann.bsky.social · 30/06/2025

Thank you for sharing! It was a pleasure working on this, together with @twittlabs.bsky.social , @jnkt.bsky.social and many others...

062

bastianengel.bsky.social @bastianengel.bsky.social · 19/05/2025

Whom to treat in #AIH #cirrhosis with decompensation? 💊 Steroids if: 🧠 encephalopathy equal or less than grade 2 📈 MELD-Na 28 or below 🚒If patients with AIH do not meet this criteria #transplant might be the better option. #liversky @easlnews.bsky.social authors.elsevier.com/c/1l6Pu5UiFS...

authors.elsevier.com

010

Reposted by @bastianengel.bsky.social

Journal of Hepatology @jhepatology.bsky.social · 10/05/2025

🆕CPG in press❕ EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease Find it here👉https://bit.ly/3GM9EEB #LiverSky @easlnews.bsky.social

197

Reposted by @bastianengel.bsky.social

Emma R Andersson @anderssonlab.bsky.social · 07/05/2025

Can’t wait for #EASL2025! @easlnews.bsky.social Join Colm O’Rourke and me, on Friday for a session we’ve designed and are thrilled to chair: “Do’s and Don’ts in Liver Transcriptomics” Arnold Room | 3–4PM Come for insights, tips & tricks from Neil Henderson, Johan Ankarklev, & Simon Cockell!

133

Reposted by @bastianengel.bsky.social

Journal of Hepatology @jhepatology.bsky.social · 03/04/2025

🆕CPG❕ EASL Clinical Practice Guidelines on TIPS ✅Addresses all aspects of #TIPS in patients with #cirrhosis Full text here: bit.ly/4hZuMUK #LiverSky @easlnews.bsky.social

0137

Reposted by @bastianengel.bsky.social

TherVacB Project @thervacb-eu.bsky.social · 02/04/2025

🤔How is #hepD treated? Why is this relevant for #hepB patients? 🇩🇪🗺️ 🎞️Watch insights from #internists 🥼#HelenieKefalakes #LisaSandmann in our fresh release youtu.be/d7dV2G6tMXA #hepatitisawareness📺with experts answering key #HBV #HDV questions #MHH #B_Aware #D-SOLVE #LiverHealth #LiverSky #HepSky

youtu.be

How is hepatitis D treated?

YouTube video by TherVacB - Awareness & Insights on Hepatitis B

123

Reposted by @bastianengel.bsky.social

Zunamys Carrero @zcarrero-katherlab.bsky.social · 31/03/2025

✮ Kather Lab is hiring PostDocs & Software Engineers! ☞ Strong Python & PyTorch skills, GitHub experience, and interest in LLMs & computational pathology required.    Apply here╰( ͡° ͜ʖ ͡° )つ──☆*・ﾟ: bit.ly/42nY62u

0102

Reposted by @bastianengel.bsky.social

Jakob Nikolas Kather @jnkt.bsky.social · 27/03/2025

Happy to share our latest paper in @ai.nejm.org, led by Isabella Wiest: "Deidentifying Medical Documents with Local, Privacy-Preserving Large Language Models: The LLM-Anonymizer" ai.nejm.org/doi/full/10.... You can use our open source tool with local LLMs to robustly de-identify medical documents.

195

Reposted by @bastianengel.bsky.social

Elliot Tapper @ebtapper.bsky.social · 04/03/2025

Spicy! Adding lasix to the management of hepatorenal syndrome might be ok if you bump the MAP with pressors @juancarlosqvelez.bsky.social doi.org/10.1016/j.ek... #nephsky #liversky

2258

bastianengel.bsky.social @bastianengel.bsky.social · 21/02/2025

Find the latest evidence on #autoimmune #liver diseases (in German, but #AI will help to translate) in which we summarize the latest evidence, finally on the highest level achievable for guidelines. This highlights the progress in the #AILD field in the last years. www.dgvs.de/leitlinien/l...

dgvs.de

Seltene Lebererkrankungen (LeiSe LebEr) - DGVS - Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten

010

bastianengel.bsky.social @bastianengel.bsky.social · 20/02/2025

Fresh from #Hepatology, cross-sectional multicenter study on Quality of Life in #AIH. 👍 882 patients, 178 controls across Europe #ERN 👎 QoL impaired mainly by physical complaints 📈 QoL correlated w/ depression/anxiety 💊 remission associated w/ improved symptoms doi.org/10.1097/HEP.0000000000001271

doi.org

ted outcome measures. Methods: Adult AIH patients diagnosed at 12 European centers were enrolled in this prospective, cross-sectional study from July 2020-June 2023. HRQoL was assessed using the Ph...

100

Reposted by @bastianengel.bsky.social

EASL @easlnews.bsky.social · 19/02/2025

In today's #readoftheweek📚 learn about the ALNE model and how it generates quantitative and accurate differential diagnosis between cases with AIH or PBC. Read here this JHEP Reports article: www.jhep-reports.eu/article/S258... @jhepatology.bsky.social #LiverSky

074

bastianengel.bsky.social @bastianengel.bsky.social · 20/02/2025

Happy to have contributed to this project led by @aleger87.bsky.social 🤖 ML-based detection of AIH and PBC from H&E stained slides 💥 solid performance with heterogenous staining/scanning 😳 no annotation needed More to come and looking forward to it! @jnkt.bsky.social #liversky

041

bastianengel.bsky.social @bastianengel.bsky.social · 18/02/2025

🔥 off the press. Multicenter study using proteomic signatures to identify biomarker candidates in acute liver failure led by Pavel Strnad from Aachen. 🏨 disriminate APAP from non-APAP 📉 predict transplant-free survival from 🩸 🧮 outperform MELD and AFLSG-PI Great work 👏 doi.org/10.1016/j.jh...

doi.org

Redirecting

100

Reposted by @bastianengel.bsky.social

Jan Clusmann @janclusmann.bsky.social · 18/02/2025

The autoimmune hepatitis field is quite unique in the way clinicians and researchers on AIH are connected personally worldwide. Optimal starting point for generalizable prediction algorithms ...

011

bastianengel.bsky.social @bastianengel.bsky.social · 18/02/2025

Starting on Bluesky with our summary about most pressing issues in #AIH 🤖 Employing AI for research and patient information 🧬 Unveil pathogenesis by using single cell techniques 🧪 new biomarkers, validate candidates 📊 New clinical trials, harmonize outcome sets www.jhep-reports.eu/article/S258...

jhep-reports.eu

Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024

Autoimmune hepatitis (AIH) is a rare chronic liver disease with an increasing incidence in many countries. Chronic autoimmune responses against the liver can cause hepatic and extrahepatic symptoms, d...

140

Reposted by @bastianengel.bsky.social

Nature Portfolio @natureportfolio.nature.com · 10/02/2025

Two papers in Nature Climate Change suggest that exceeding 1.5 °C in 2024 may indicate that we have entered a multi-decadal period of 1.5 °C average global warming. go.nature.com/4hR9GYO go.nature.com/3WVdJM1 🧪

This is figure 2 from “A year above 1.5 °C signals that Earth is most probably within the 20-year period that will reach the Paris Agreement limit.” It shows strong warming trends place the first 1.5 °C year within the 1.5 °C 20-year period.

04926

Reposted by @bastianengel.bsky.social

Rob Brierley @robbrierley.bsky.social · 21/01/2025

Thermal ablation vs surgical resection of small colorectal liver metastases (COLLISION trial) “The assumption that thermal ablation should be reserved for unresectable colorectal liver mets requires re-evaluation” www.thelancet.com/journals/lan... #GastroSky #OncSky #MedSky @oncoalert.bsky.social

0115